Nicofuranose
From Wikipedia, the free encyclopedia
|
Nicofuranose
|
|
| Systematic (IUPAC) name | |
| [(2R,3S,4R,5R)-2-hydroxy-4-(pyridine-3-carbonyloxy)-2,5-bis(pyridine-3-carbonyloxymethyl)oxolan-3-yl] pyridine-3-carboxylate | |
| Identifiers | |
| CAS number | ? |
| ATC code | C10 |
| PubChem | |
| Chemical data | |
| Formula | C30H24N4O10 |
| Mol. mass | 600.533 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Nicofuranose is a niacin derivative used as a hypolipidemic agent.
|
||||||||||||||||||||||||||

